Scientists will assess the potential of psychedelic compounds for treating addiction ISSAQUAH, Wash., November 16, 2021 ( – CaaMTech, Inc. announced today that the company has entered into a research collaboration with the University of Wyoming’s School of Pharmacy. The collaboration will evaluate CaaMTech’s proprietary compounds in addiction models as well as aim to demonstrate their…


Previous articleAwakn Life Sciences Signs MOU with NHS (Devon Partnership NHS Trust) and University of Exeter with a View of Increasing Access to Psychedelic-Assisted Psychotherapy in the UK
Next articleThe Serotonin 5-HT2A Receptor: From Mice to Humans